Literature DB >> 31763281

Evaluation of Patients for Endoscopic DCR: Sac Syringing and Radionuclide Scintigraphy.

Col Uma Patnaik1, Maj Atul Gupta2, Brig Ajith Nilakantan3.   

Abstract

To evaluate the importance of sac syringing and radionuclide scintigraphy for pre operative work up of patients with epiphora. In this study, from the year Jan. 2013 to Jan. 2016, patients of epiphora were subjected to radionuclide scintigraphy of lacrimal apparatus in addition to sac syringing and probing. The significance of adding radionuclide scintigraphy in pre op assessment of epiphora was statistically assessed. 146 lacrimal systems were enrolled in the study. Out of them, 89 were males and 57 were females. The mean age of the patients was 42 years. Of the 146 lacrimal systems evaluated, scintigraphy detected 25 cases of common canalicular block versus 8 cases by sac syringing. Also radionuclide scintigraphy was able to detect 11 cases of functional obstruction which were patent on syringing. Results were analysed statistically. Correct diagnosis of site of obstruction is essential to predict a better surgical outcome of endoscopic DCR as it is a highly successful surgical procedure which can be done in distal NLDO only. We recommend that all patients of epiphora should undergo sac syringing as an initial test. This is a simple, inexpensive procedure which can be done as an OPD procedure in a short time. However, radionuclide scintigraphy can be added as an additional investigation to more accurately delineate site of block. It is an objective test and delineates the lacrimal system both anatomically and functionally. Also it diagnoses functional block which appears patent on syringing. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Dacryocystorhinostomy; Epiphora; Radionuclide scintigraphy; Sac syringing

Year:  2018        PMID: 31763281      PMCID: PMC6848428          DOI: 10.1007/s12070-018-1404-6

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  17 in total

1.  Quantitative lacrimal scintillography. II. Lacrimal pathology.

Authors:  J J Hurwitz; M N Maisey; R A Welham
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

2.  Assessment of functional nasolacrimal duct obstruction--a survey of ophthalmologists in the southwest.

Authors:  F M Cuthbertson; S Webber
Journal:  Eye (Lond)       Date:  2004-01       Impact factor: 3.775

3.  Radiography in functional lacrimal testing.

Authors:  J J Hurwitz; R A Welham
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

4.  Infrequently performed studies in nuclear medicine: Part 1.

Authors:  Anita MacDonald; Steven Burrell
Journal:  J Nucl Med Technol       Date:  2008-08-14

5.  Scintigraphy and contrast radiography for epiphora.

Authors:  J D Rose; C B Clayton
Journal:  Br J Radiol       Date:  1985-12       Impact factor: 3.039

6.  A new method of evaluating lacrimal drainage.

Authors:  R M Rossomondo; W H Carlton; J H Trueblood; R P Thomas
Journal:  Arch Ophthalmol       Date:  1972-11

7.  Intubation macrodacryocystography and quantitative scintillography: the "complete" lacrimal assessment.

Authors:  J J Hurwitz; R A Welham; M N Maisey
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1976 Jul-Aug

8.  The clinical value of dacryoscintigraphy in the selection of surgical approach for patients with functional lacrimal duct obstruction.

Authors:  Yong An Chung; Ie Ryung Yoo; Joung Sik Oum; Sung Hoon Kim; Hyung Sun Sohn; Soo Kyo Chung
Journal:  Ann Nucl Med       Date:  2005-09       Impact factor: 2.668

9.  Comparison of dacryocystography and lacrimal scintigraphy in the diagnosis of functional nasolacrimal duct obstruction.

Authors:  M J Wearne; J Pitts; J Frank; G E Rose
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

10.  Investigation and endoscopic treatment for functional and anatomical obstruction of the nasolacrimal duct system.

Authors:  P J Wormald; A Tsirbas
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.